In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bio-Rad Laboratories Inc.

www.bio-rad.com

Latest From Bio-Rad Laboratories Inc.

Avanos/Halyard Tops Recent Medtech CEO-To-Worker Pay Ratio Disclosures

While most device companies filing 2017 annual reports in the first half of 2018 showed CEO-to-worker pay ratios averaging 219:1, Halyard Health (recently renamed Avanos Medical) CEO Joseph F. Woody was compensated 1,250 times what the company’s median employee earned, according to recent disclosures. Medtech Insight also examined CEO-to-worker pay ratios at Align Technologies, Abbott Laboratories, Danaher and Bio-Rad Laboratories, among other firms.

Leadership Companies

Market Intel: Liquid Biopsy I – Analyzing Market Landmarks And Landmines

The worldwide liquid biopsy market is expected to reach $2.0bn by 2022, according to a new report by Meddevicetracker, "Oncology: Liquid Biopsy Products." The growth is driven by the rising global incidence of cancers, which, in turn, fuels innovation among companies to develop noninvasive diagnostic assays that obviate the need for tissue biopsy. This is the first in a two-part series providing an overview of the liquid biopsy market, as well as the technologies developed by the larger players in this space, and examining the biggest barriers and growth drivers. In the second part, we'll take a closer look at emerging companies in the sector and offer key insights from C-level attendees at the recent Liquid Biopsy Conference in San Francisco.

Cancer In Vitro Diagnostics

Antimicrobial Susceptibility Test-Makers Seek Ways To Shorten FDA Clearance Process

A group of antimicrobial susceptibility test manufacturers are working with US FDA regulators to hasten the clearance process for their products. The agency recent convened a workshop at its Maryland headquarters to help address the issue.

In Vitro Diagnostics Regulation

US FDA Details Special Controls For Six Device Types

The classification orders touch on surgical, weight loss and cardiac devices and diagnostics.

Medical Device Regulation
See All

Company Information

  • Industry
  • Distributors
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
  • Therapeutic Areas
  • Immune Disorders
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Bio-Rad Laboratories Inc.
  • Senior Management
  • Norman Schwartz, Pres. & CEO
    Christine Tsingos, EVP, CFO
    Mike Crowley, EVP, Global Commercial Ops.
    Andrew Last, EVP, COO
  • Contact Info
  • Bio-Rad Laboratories Inc.
    Phone: (510) 724-7000
    4000 Alfred Nobel Dr.
    Hercules, CA 94547
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register